A 20-Year Retrospective of Kidney Cancer Journal: 2003-2022

Abstract

These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.